Author:
Sawatdee Somchai,Changsan Narumon,Srichana Teerapol,Nanjwade Basavaraj
Publisher
Springer Nature Singapore
Reference85 articles.
1. Boddu S, Nesamony J. Nanocarrier systems for lung drug delivery. In: Pathak Y, Islam N, editors. Handbook of lung targeted drug delivery systems: recent trends and clinical evidences. Boca Raton: CRC Press; 2022.
2. Katiyar SK, Gaur SN, Solanki RN, et al. Indian guideline on nebulization therapy. Indian J Tuberc. 2022;69:S1–S191.
3. Lavorini F. The challenge of delivering therapeutic aerosols to asthma patients. Allergy. 2013:102418.
4. Dalby R, Spallek M, Voshaar T. A review of the development of Respimat® soft mist™ inhaler. Int J Pharm. 2004;283(1–2):1–9.
5. Iwanaga T, Tohda Y, Nakamura S, Suga Y. The Respimat® soft mist inhaler: implications of drug delivery characteristics for patients. Clin Drug Investig. 2019;39:1021–30.